Indolequinone Antitumor Agents: Correlation between Quinone Structure, Rate of Metabolism by Recombinant Human NAD(P)H:Quinone Oxidoreductase, and in Vitro Cytotoxicity

This publication has 18 references indexed in Scilit:

• A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity
  British Journal of Cancer, 1996
• Factors affecting sensitivity to EO9 in rodent and human tumour cells in vitro: DT-diaphorase activity and hypoxia
  European Journal Of Cancer, 1994
• Cyclopropamitosenes
  Anti-Cancer Drugs, 1994
• DT-diaphorase in activation and detoxification of quinones
  Cancer and Metastasis Reviews, 1993
• The one-electron reduction potential of several substrates can be related to their reduction rates by cytochrome P-450 reductase
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1993
• The sensitivity of human tumour cells to quinone bioreductive drugs: What role for DT-diaphorase?
  Biochemical Pharmacology, 1992
• The Role of NAD(P)H: Quinone Reductase (EC 1.6.99.2, DT-Diaphorase) in the Reductive Bioactivation of the Novel Indoloquinone Antitumor Agent E09
  Cancer Communications, 1991
• [31] Antioxidant activities of bile pigments: Biliverdin and bilirubin
  Published by Elsevier ,1990
• Anaerobic reduction of nitroimidazoles by reduced flavin mononucleotide and by xanthine oxidase
  Biochemical Pharmacology, 1980
• [57] Beef heart TPNH-DPN pyridine nucleotide transhydrogenases
  Published by Elsevier ,1967